20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Methotrexate in Cancer Treatment: Mechanisms and Clinical Applications

Methotrexate (CAS 59-05-2) has been a pivotal agent in the fight against cancer for decades, primarily functioning as a potent chemotherapy drug. Its efficacy stems from its classification as an antifolate and antimetabolite. The core of its methotrexate mechanism of action in oncology lies in its ability to competitively inhibit the enzyme dihydrofolate reductase (DHFR). This inhibition prevents the conversion of dihydrofolate to tetrahydrofolate, a vital cofactor required for the synthesis of purines and thymidylate, which are essential components of DNA. By disrupting DNA synthesis and repair, Methotrexate preferentially targets rapidly proliferating cells, a hallmark of cancer cells, thus halting tumor growth.

The methotrexate uses in cancer treatment are diverse, encompassing a wide array of malignancies. It is employed in the treatment of acute lymphoblastic leukemias, non-Hodgkin's lymphomas, osteosarcomas, and various solid tumors, including those of the breast, head and neck, lungs, and bladder. It can be administered as a single agent or in combination with other chemotherapy drugs, often at much higher doses than those used for autoimmune diseases. The specific methotrexate dosage and administration schedule are meticulously determined by the type and stage of cancer being treated.

Despite its potent anti-cancer activity, Methotrexate is associated with significant side effects, necessitating careful patient monitoring and management. Potential methotrexate side effects can range from mucositis and myelosuppression to more severe organ toxicity. Furthermore, understanding potential methotrexate drug interactions and the stringent methotrexate pregnancy warning is crucial for patient safety. For healthcare providers and researchers interested in this vital chemotherapy agent, the ability to purchase Methotrexate underscores its ongoing importance in oncological treatment and research.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Methotrexate in Rheumatoid Arthritis: Efficacy, Side Effects, and Monitoring

Next: The Science Behind Anagrelide Hydrochloride: A Key Player in Thrombocythemia Treatment

All Rights Reserved